NEW YORK, Nov. 20 — IBM and Australian proteomics firm Proteome Systems have formed an international proteomics-analysis alliance, the companies said on Tuesday.
Under the agreement, IBM, based in Armonk, NY, will supply the IT infrastructure for Proteome Systems' new discovery platform and provide hardware, software, support, and education and marketing programs for the company's ongoing research.
Proteome Systems, based in Sydney, is currently developing a new version of its proteomics discovery platform, to be called ProteomIQ(a), and plans its launch for some time next year.
The partnership was originally reported in the Nov. 12 issue of ProteoMonitor.
"There's a lot of work that has gone into making sure all of the different elements of the platform integrate, and we haven't established this on any platform other than the IBM platform and we probably won't," Proteome Systems CEO Keith Williams told ProteoMonitor.
For the company's in-house research IBM will provide its next-generation UNIX server, the IBM eServer(b) p690, or "Regatta," which includes two processors that top one-gigahertz capability and new capability to maintain function during major system failures.
Proteome Systems will also have access to IBM's worldwide marketing and technical support programs.
This is the latest in a series of proteomics-based partnerships for IBM's Life Sciences division. In the last year, the division also struck deals with MDS-Proteomics and Structural Bioinformatics.